These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34035170)

  • 1. Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived
    Pak C; Danko T; Mirabella VR; Wang J; Liu Y; Vangipuram M; Grieder S; Zhang X; Ward T; Huang YA; Jin K; Dexheimer P; Bardes E; Mitelpunkt A; Ma J; McLachlan M; Moore JC; Qu P; Purmann C; Dage JL; Swanson BJ; Urban AE; Aronow BJ; Pang ZP; Levinson DF; Wernig M; Südhof TC
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34035170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1.
    Pak C; Danko T; Zhang Y; Aoto J; Anderson G; Maxeiner S; Yi F; Wernig M; Südhof TC
    Cell Stem Cell; 2015 Sep; 17(3):316-28. PubMed ID: 26279266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling Mechanisms of Patient-Specific NRXN1 Mutations in Neuropsychiatric Diseases Using Human Induced Pluripotent Stem Cells.
    De Los Angeles A; Tunbridge EM
    Stem Cells Dev; 2020 Sep; 29(17):1142-1144. PubMed ID: 32122280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids.
    Sebastian R; Jin K; Pavon N; Bansal R; Potter A; Song Y; Babu J; Gabriel R; Sun Y; Aronow B; Pak C
    Nat Commun; 2023 Jun; 14(1):3770. PubMed ID: 37355690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal impact of patient-specific aberrant NRXN1α splicing.
    Flaherty E; Zhu S; Barretto N; Cheng E; Deans PJM; Fernando MB; Schrode N; Francoeur N; Antoine A; Alganem K; Halpern M; Deikus G; Shah H; Fitzgerald M; Ladran I; Gochman P; Rapoport J; Tsankova NM; McCullumsmith R; Hoffman GE; Sebra R; Fang G; Brennand KJ
    Nat Genet; 2019 Dec; 51(12):1679-1690. PubMed ID: 31784728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review.
    Castronovo P; Baccarin M; Ricciardello A; Picinelli C; Tomaiuolo P; Cucinotta F; Frittoli M; Lintas C; Sacco R; Persico AM
    Clin Genet; 2020 Jan; 97(1):125-137. PubMed ID: 30873608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models.
    Zeng L; Zhang P; Shi L; Yamamoto V; Lu W; Wang K
    PLoS One; 2013; 8(3):e59685. PubMed ID: 23536886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single cell analysis of autism patient with bi-allelic NRXN1-alpha deletion reveals skewed fate choice in neural progenitors and impaired neuronal functionality.
    Lam M; Moslem M; Bryois J; Pronk RJ; Uhlin E; Ellström ID; Laan L; Olive J; Morse R; Rönnholm H; Louhivuori L; Korol SV; Dahl N; Uhlén P; Anderlid BM; Kele M; Sullivan PF; Falk A
    Exp Cell Res; 2019 Oct; 383(1):111469. PubMed ID: 31302032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRXN1α
    Avazzadeh S; Quinlan LR; Reilly J; McDonagh K; Jalali A; Wang Y; McInerney V; Krawczyk J; Ding Y; Fitzgerald J; O'Sullivan M; Forman EB; Lynch SA; Ennis S; Feerick N; Reilly R; Li W; Shen X; Yang G; Lu Y; Peeters H; Dockery P; O'Brien T; Shen S; Gallagher L
    BMC Neurosci; 2021 Sep; 22(1):56. PubMed ID: 34525970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders.
    Hu Z; Xiao X; Zhang Z; Li M
    Mol Psychiatry; 2019 Oct; 24(10):1400-1414. PubMed ID: 31138894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
    Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
    Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical relevance of intragenic
    Cosemans N; Vandenhove L; Vogels A; Devriendt K; Van Esch H; Van Buggenhout G; Olivié H; de Ravel T; Ortibus E; Legius E; Aerssens P; Breckpot J; R Vermeesch J; Shen S; Fitzgerald J; Gallagher L; Peeters H
    J Med Genet; 2020 May; 57(5):347-355. PubMed ID: 31932357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes.
    Mozhui K; Wang X; Chen J; Mulligan MK; Li Z; Ingles J; Chen X; Lu L; Williams RW
    Transl Psychiatry; 2011 Jul; 1(7):e25. PubMed ID: 22832527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila.
    Zweier C; de Jong EK; Zweier M; Orrico A; Ousager LB; Collins AL; Bijlsma EK; Oortveld MA; Ekici AB; Reis A; Schenck A; Rauch A
    Am J Hum Genet; 2009 Nov; 85(5):655-66. PubMed ID: 19896112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia.
    Ishizuka K; Yoshida T; Kawabata T; Imai A; Mori H; Kimura H; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Morikawa M; Okada T; Ikeda M; Branko A; Mori D; Someya T; Iwata N; Ozaki N
    J Neurodev Disord; 2020 Sep; 12(1):25. PubMed ID: 32942984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal rhythms in neurexins transcripts and inhibitory/excitatory synapse scaffold proteins in the biological clock.
    Shapiro-Reznik M; Jilg A; Lerner H; Earnest DJ; Zisapel N
    PLoS One; 2012; 7(5):e37894. PubMed ID: 22662246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
    Aksu Uzunhan T; Ayaz A
    Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare heterozygous genetic variants of NRXN and NLGN gene families involved in synaptic function and their association with neurodevelopmental disorders.
    Gerik-Celebi HB; Bolat H; Unsel-Bolat G
    Dev Neurobiol; 2024 Jul; 84(3):158-168. PubMed ID: 38739110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further insight into the neurobehavioral pattern of children carrying the 2p16.3 heterozygous deletion involving NRXN1: Report of five new cases.
    Alfieri P; Scibelli F; Sinibaldi L; Valeri G; Caciolo C; Novello RL; Novelli A; Digilio MC; Tartaglia M; Vicari S
    Genes Brain Behav; 2020 Sep; 19(7):e12687. PubMed ID: 32658356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
    Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
    Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.